In HCC there is an increase in ERK5 nuclear localisation but no increase in ERK5 kinase activity [83], and overexpression of the oncogene, Cdc37, promotes kinase-inactive nuclear localisation of ERK5 while increasing cell proliferation [22]. Here, MAPK7 is linked to hepatocellular carcinoma.